GH Research (GHRS) Invested Capital (2021 - 2025)
GH Research (GHRS) recorded quarterly Invested Capital of $279.7 million in Q4 2025, down 4.01% quarter-over-quarter from $291.4 million in Q3 2025, and up 56.3% on a YoY basis from $179.0 million in Q4 2024.
GH Research (GHRS) Invested Capital (2021 - 2025) Analysis & Trends
GH Research's Invested Capital history runs 5 years deep, the most recent figure standing at $279.7 million for Q4 2025.
- In Q4 2025, Invested Capital rose 56.3% year-over-year to $279.7 million; the TTM figure through Dec 2025 stood at $279.7 million (up 56.3% YoY), while the FY2025 annual figure was $279.7 million, up 56.3% from the prior year.
- Invested Capital was $279.7 million for Q4 2025 at GH Research, down from $291.4 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $310.2 million in Q1 2025 to a low of $179.0 million in Q4 2024.
- Historically, Invested Capital has averaged $248.9 million across 5 years, with a median of $253.3 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Invested Capital decreased 18.28% in 2024, then jumped 56.3% in 2025.
- A 5-year view of Invested Capital shows it stood at $277.2 million in 2021, then dropped by 9.87% to $249.8 million in 2022, then declined by 12.35% to $219.0 million in 2023, then dropped by 18.28% to $179.0 million in 2024, then surged by 56.3% to $279.7 million in 2025.
- The last three Invested Capital figures came in at $279.7 million (Q4 2025), $291.4 million (Q3 2025), and $303.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 502.95 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 279.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 279.70 Mn |
| Sep 30, 2025 | 291.40 Mn |
| Jun 30, 2025 | 303.18 Mn |
| Mar 31, 2025 | 310.21 Mn |
| Dec 31, 2024 | 178.95 Mn |
| Sep 30, 2024 | 189.37 Mn |
| Jun 30, 2024 | 198.68 Mn |
| Mar 31, 2024 | 209.75 Mn |
| Dec 31, 2023 | 218.97 Mn |
| Sep 30, 2023 | 225.77 Mn |
| Jun 30, 2023 | 232.98 Mn |
| Mar 31, 2023 | 241.83 Mn |
| Dec 31, 2022 | 249.82 Mn |
| Sep 30, 2022 | 256.74 Mn |
| Jun 30, 2022 | 263.22 Mn |
| Mar 31, 2022 | 269.48 Mn |
| Dec 31, 2021 | 277.18 Mn |
| Sep 30, 2021 | 283.60 Mn |